Sterling, Timothy R <br/><br/>
Three months of rifapentine and isoniazid for latent tuberculosis infection.  [electronic resource] 

 -  The New England journal of medicine  Dec 2011 
 - 2155-66 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1533-4406 
<br/><br/><label>Standard No.: </label>10.1056/NEJMoa1104875  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antitubercular Agents--administration & dosage<br/>Directly Observed Therapy<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Follow-Up Studies<br/>Humans<br/>Intention to Treat Analysis<br/>Isoniazid--administration & dosage<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Rifampin--administration & dosage<br/>Risk Factors<br/>Self Administration<br/>Tuberculosis--drug therapy<br/>Virus Latency